EP2308477
Rasagílín lyfjaform með seinkaða losun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.1.2010EP published:
9.5.2012EP application number:
10186379.3
EP translation filed:
29.8.2012Grant published:
15.9.2012EPO information:
European Patent Register
Max expiry date:
21.1.2030Expiry date:
21.1.2019
Title:
Delayed release rasagiline formulation
Timeline
Today
22.1.2010EP application
9.5.2012EP Publication
29.8.2012Translation submitted
15.9.2012Registration published
21.1.2019Expires
Owner
Name:
TEVA PHARMACEUTICAL INDUSTRIES, LTD.Address:
5 Basel Street, P.O. Box 3190, 49131, Petah Tiqva, IL
Inventor
Name:
Safadi, MuhammadAddress:
Nazareth, IL
Name:
Licht, DaniellaAddress:
Givat-Shmuel, IL
Name:
Cohen, RachelAddress:
Hadera, IL
Name:
Frenkel, AntonAddress:
Netanya, IL
Name:
Zholkovsky, MarinaAddress:
Bat-Yam, IL
Name:
Koltai, TamasAddress:
Netanya, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
689044Date:
18.1.2010Country:
US
Number:
455976Date:
9.6.2009Country:
US
Number:
456001Date:
9.6.2009Country:
US
Number:
456029Date:
9.6.2009Country:
US
Number:
456031Date:
9.6.2009Country:
US
Number:
205833 PDate:
23.1.2009Country:
US
Classification
Categories:
A61K 9/20, A61K 31/135
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 20.12.2012
Expires: 21.1.2014
Payer: G. H. Sigurgeirsson
Number: 5
Paid: 20.12.2013
Expires: 21.1.2015
Payer: G. H. Sigurgeirsson
Number: 6
Paid: 19.12.2014
Expires: 21.1.2016
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 21.12.2015
Expires: 21.1.2017
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 12.12.2016
Expires: 21.1.2018
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 15.12.2017
Expires: 21.1.2019
Payer: G. H. Sigurgeirsson